Measuring naturally acquired immune responses to candidate malaria vaccine antigens in Ghanaian adults

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Dodoo, Daniel ^a   Hollingdale, Michael R ^b   Anum, Dorothy ^a   Koram, Kwadwo A ^a   Gyan, Ben ^a   Akanmori, Bartholomew D ^a,c   Ocran, Josephine ^a   Adu Amankwah, Susan ^a   Geneshan, Harini ^b   Abot, Esteban ^b   Legano, Jennylyn ^b   Banania, Glenna ^b   Sayo, Renato ^b   Brambilla, Donald ^d   Kumar, Sanjai ^e   Doolan, Denise L ^g   Rogers, William O ^a,f   Epstein, Judith ^b   Richie, Thomas L ^b   Sedegah, Martha ^b  

^a University of Ghana   (Ghana)

^b NAVAL MEDICAL RESEARCH CENTER   (United States)

^c WHO REGIONAL OFFICE FOR AFRICA   (Congo)

^d RTI INTERNATIONAL   (United States)

^e CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^f US Naval Medical Research Unit No 3 Egypt   (Egypt)

^g QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTIGEN CSP; ANTIGEN EXP1; ANTIGEN LSA1; ANTIGEN MSP1; ANTIGEN MSP3; ANTIGEN SSP2; ANTIGEN TRAP; GAMMA INTERFERON; HLA A ANTIGEN; HLA B ANTIGEN; MALARIA VACCINE; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; PARASITE ANTIGEN; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; ERYTHROCYTE; FEMALE; GEOGRAPHIC DISTRIBUTION; GHANA; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; RURAL AREA; SPOROZOITE; T LYMPHOCYTE; URBAN AREA; ADOLESCENT; BLOOD; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; MALARIA FALCIPARUM; MIDDLE AGED; REPRODUCIBILITY; RURAL POPULATION; SECRETION; URBAN POPULATION;

ADOLESCENT; ADULT; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GHANA; HUMANS; INTERFERON-GAMMA; MALARIA VACCINES; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PLASMODIUM FALCIPARUM; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; RURAL POPULATION; T-LYMPHOCYTES; URBAN POPULATION; YOUNG ADULT;

EID: 79959222618     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-168     Document Type: Article

References (68)

1. Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans. SM Todryk P Bejon T Mwangi M Plebanski B Urban K Marsh AV Hill KL Flanagan, PLoS ONE 2008 3 2027 10.1371/journal.pone.0002027 18446217
2. The relationship between anti-merozoite antibodies and incidence of Plasmodium falciparum malaria: A systematic review and meta-analysis. FJ Fowkes JS Richards JA Simpson JG Beeson, PLoS Med 7 1000218
3. Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children. CC John AJ Tande AM Moormann PO Sumba DE Lanar XM Min JW Kazura, J Infect Dis 2008 197 519 526 10.1086/526787 18275273 (Pubitemid 351321528)
4. Development of immunity in natural Plasmodium falciparum malaria: antibodies to the falciparum sporozoite vaccine 1 antigen (R32tet32). HK Webster EF Boudreau LW Pang B Permpanich P Sookto RA Wirtz, J Clin Microbiol 1987 25 1002 1008 2439533 (Pubitemid 17084328)
5. Characterization of Plasmodium yoelii monoclonal antibodies directed against stage-specific sporozoite antigens. Y Charoenvit MF Leef LF Yuan M Sedegah RL Beaudoin, Infect Immun 1987 55 604 608 2434426 (Pubitemid 17021948)
6. Assessment of positivity in immuno-assays with variability in background measurements: a new approach applied to the antibody response to Plasmodium falciparum MSP2. A Irion HP Beck T Smith, J Immunol Methods 2002 259 111 118 10.1016/S0022-1759(01)00500-2 11730846 (Pubitemid 33124389)
7. Stability of interferon-gamma and interleukin-10 responses to Plasmodium falciparum liver stage antigen 1 and thrombospondin-related adhesive protein immunodominant epitopes in a highland population from Western Kenya. AM Moormann PO Sumba DJ Tisch P Embury CH King JW Kazura CC John, Am J Trop Med Hyg 2009 81 489 495 19706920
8. Temporal stability of naturally acquired immunity to Merozoite Surface Protein-1 in Kenyan adults. AE Dent K Chelimo PO Sumba MD Spring BS Crabb AM Moormann DJ Tisch JW Kazura, Malar J 2009 8 162 10.1186/1475-2875-8-162 19607717
9. Ex vivo interferon-gamma immune response to thrombospondin-related adhesive protein in coastal Kenyans: longevity and risk of Plasmodium falciparum infection. KL Flanagan T Mwangi M Plebanski K Odhiambo A Ross E Sheu M Kortok B Lowe K Marsh AV Hill, Am J Trop Med Hyg 2003 68 421 430 12875291 (Pubitemid 38230642)
10. Recognition of dominant T cell-stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian children. EM Riley SJ Allen S Bennett PJ Thomas A O'Donnell SW Lindsay MF Good BM Greenwood, Trans R Soc Trop Med Hyg 1990 84 648 657 10.1016/0035-9203(90)90133-Y 1703674 (Pubitemid 20358571)
11. Cytotoxic T cell reactivity and HLA-B35 binding of the variant Plasmodium falciparum circumsporozoite protein CD8+ CTL epitope in naturally exposed Kenyan adults. V Udhayakumar JM Ongecha YP Shi M Aidoo AS Orago AJ Oloo WA Hawley BL Nahlen SL Hoffman WR Weiss,, et al. Eur J Immunol 1997 27 1952 1957 10.1002/eji.1830270819 9295031 (Pubitemid 27346010)
12. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. AV Hill J Elvin AC Willis M Aidoo CE Allsopp FM Gotch XM Gao M Takiguchi BM Greenwood AR Townsend,, et al. Nature 1992 360 434 439 10.1038/360434a0 1280333
13. Naturally acquired CD8+ cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. M Sedegah BK Sim C Mason T Nutman A Malik C Roberts A Johnson J Ochola D Koech B Were,, et al. J Immunol 1992 149 966 971 1634778
14. The human immune response against the major merozoite surface antigen of Plasmodium falciparum. A Crisanti HM Muller, Parassitologia 1991 33 71 77 1841197
15. Immune responses to P. falciparum-MSP1 antigen: lack of correlation between antibody responses and the capacity of peripheral cellular immune effectors to respond to this antigen in vitro. TO Diallo CM Nguer A Dieye A Spiegel R Perraut O Garraud, Immunol Lett 1999 67 217 221 10.1016/S0165-2478(99) 00016-4 10369129 (Pubitemid 29219767)
16. Identification of frequently recognized dimorphic T-cell epitopes in plasmodium falciparum merozoite surface protein-1 in West and East Africans: lack of correlation of immune recognition and allelic prevalence. EA Lee KL Flanagan K Odhiambo WH Reece C Potter R Bailey K Marsh M Pinder AV Hill M Plebanski, Am J Trop Med Hyg 2001 64 194 203 11442217 (Pubitemid 32565850)
17. Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malaria. EA Lee DR Palmer KL Flanagan WH Reece K Odhiambo K Marsh M Pinder MB Gravenor WA Keitel KE Kester,, et al. Infect Immun 2002 70 1417 1421 10.1128/IAI.70.3.1417-1421.2002 11854228 (Pubitemid 34163419)
18. Cellular responses to Plasmodium falciparum erythrocyte membrane protein-1: use of relatively conserved synthetic peptide pools to determine CD4 T cell responses in malaria-exposed individuals in Benin, West Africa. LA Sanni CE Allsopp L Reubsaet A Sanni C Newbold VS Chauhan J Langhorne, Malar J 2002 1 7 10.1186/1475-2875-1-7 12057026
19. Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1. YP Shi U Sayed SH Qari JM Roberts V Udhayakumar AJ Oloo WA Hawley DC Kaslow BL Nahlen AA Lal, Infect Immun 1996 64 2716 2723 8698500 (Pubitemid 26226838)
20. Cytotoxic T lymphocytes to Plasmodium falciparum epitopes in an area of intense and perennial transmission in Tanzania. A Lalvani N Hurt M Aidoo P Kibatala M Tanner AV Hill, Eur J Immunol 1996 26 773 779 10.1002/eji.1830260408 8625967 (Pubitemid 26118287)
21. Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. M Plebanski M Aidoo HC Whittle AV Hill, J Immunol 1997 158 2849 2855 9058821 (Pubitemid 127470545)
22. Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3. M Aidoo A Lalvani SC Gilbert JT Hu P Daubersies N Hurt HC Whittle P Druihle AV Hill, Infect Immun 2000 68 227 232 10.1128/IAI.68.1.227-232.2000 10603392 (Pubitemid 30016701)
23. Longitudinal study of natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in a holoendemic region of malaria in western Kenya: Asembo Bay Cohort Project VIII. V Udhayakumar S Kariuki M Kolczack M Girma JM Roberts AJ Oloo BL Nahlen AA Lal, Am J Trop Med Hyg 2001 65 100 107 11508382 (Pubitemid 32744213)
24. Identification of T-cell determinants in natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in an adult population exposed to malaria. AA Lal MA Hughes DA Oliveira C Nelson PB Bloland AJ Oloo WE Hawley AW Hightower BL Nahlen V Udhayakumar, Infect Immun 1996 64 1054 1059 8641760 (Pubitemid 26065590)
25. The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum. P Bejon J Mwacharo O Kai S Todryk S Keating B Lowe T Lang TW Mwangi SC Gilbert N Peshu,, et al. J Immunol 2007 179 4193 4201 17785859
26. Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy. P Romero JC Cerottini GA Waanders, Mol Med Today 1998 4 305 312 10.1016/S1357-4310(98)01280-5 9743992 (Pubitemid 28364107)
27. HLA-A*0201 restricted CD8+ T-lymphocyte responses to malaria: identification of new Plasmodium falciparum epitopes by IFN-gamma ELISPOT. JM Gonzalez K Peter F Esposito I Nebie JM Tiercy A Bonelo M Arevalo-Herrera D Valmori P Romero S Herrera,, et al. Parasite Immunol 2000 22 501 514 10.1046/j.1365-3024.2000.00331.x 11012976
28. Cellular reactivity to the p. Falciparum protein trap in adult kenyans: novel epitopes, complex cytokine patterns, and the impact of natural antigenic variation. KL Flanagan M Plebanski K Odhiambo E Sheu T Mwangi C Gelder K Hart M Kortok B Lowe KJ Robson,, et al. Am J Trop Med Hyg 2006 74 367 375 16525093 (Pubitemid 46774356)
29. Fine specificity of neonatal lymphocytes to an abundant malaria blood-stage antigen: epitope mapping of Plasmodium falciparum MSP1(33). I Malhotra AN Wamachi PL Mungai E Mzungu D Koech E Muchiri AM Moormann CL King, J Immunol 2008 180 3383 3390 18292564
30. Allele specificity of gamma interferon responses to the carboxyl-terminal region of Plasmodium falciparum merozoite surface protein 1 by Kenyan adults with naturally acquired immunity to malaria. MD Spring K Chelimo DJ Tisch PO Sumba R Rochford CA Long JW Kazura AM Moormann, Infect Immun 78 4431 4441
31. Identification and localization of minimal MHC-restricted CD8+ T cell epitopes within the Plasmodium falciparum AMA1 protein. M Sedegah Y Kim B Peters S McGrath H Ganeshan J Lejano E Abot G Banania M Belmonte R Sayo,, et al. Malar J 9 241
32. Human T cell recognition of the blood stage antigen Plasmodium hypoxanthine guanine xanthine phosphoribosyl transferase (HGXPRT) in acute malaria. T Woodberry A Pinzon-Charry KA Piera Y Panpisutchai CR Engwerda DL Doolan E Salwati E Kenangalem E Tjitra RN Price,, et al. Malar J 2009 8 122 10.1186/1475-2875-8-122 19500406
33. Gamma interferon responses to Plasmodium falciparum liver-stage antigen 1 and thrombospondin-related adhesive protein and their relationship to age, transmission intensity, and protection against malaria. CC John AM Moormann PO Sumba AV Ofulla DC Pregibon JW Kazura, Infect Immun 2004 72 5135 5142 10.1128/IAI.72.9.5135-5142.2004 15322007 (Pubitemid 39223398)
34. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. AV Hill J Elvin AC Willis M Aidoo CE Allsopp FM Gotch XM Gao M Takiguchi BM Greenwood AR Townsend,, et al. Nature 1992 360 434 439 10.1038/360434a0 1280333
35. Evaluation of cellular immune responses in subjects chronically infected with HIV type 1. TM Fu SA Dubey DV Mehrotra DC Freed WL Trigona L Adams-Muhler JH Clair TG Evans R Steigbigel JM Jacobson,, et al. AIDS Res Hum Retroviruses 2007 23 67 76 10.1089/aid.2006.0114 17263635 (Pubitemid 46214174)
36. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. DL Doolan SL Hoffman S Southwood PA Wentworth J Sidney RW Chesnut E Keogh E Appella TB Nutman AA Lal,, et al. Immunity 1997 7 97 112 10.1016/S1074-7613(00)80513-0 9252123 (Pubitemid 27357268)
37. HLA-DR-promiscuous T cell epitopes from Plasmodium falciparum pre-erythrocytic-stage antigens restricted by multiple HLA class II alleles. DL Doolan S Southwood R Chesnut E Appella E Gomez A Richards YI Higashimoto A Maewal J Sidney RA Gramzinski,, et al. J Immunol 2000 165 1123 1137 10878392 (Pubitemid 30484785)
38. Merozoite surface protein 3 and protection against malaria in Aotus nancymai monkeys. H Hisaeda A Saul JJ Reece MC Kennedy CA Long LH Miller AW Stowers, J Infect Dis 2002 185 657 664 10.1086/339187 11865423 (Pubitemid 34171471)
39. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. S Kumar A Yadava DB Keister JH Tian M Ohl KA Perdue-Greenfield LH Miller DC Kaslow, Mol Med 1995 1 325 332 8529111
40. Two-step chromatographic purification of recombinant Plasmodium falciparum circumsporozoite protein from Escherichia coli. N Kolodny S Kitov MA Vassell VL Miller LA Ware K Fegeding P De La Vega JB Sacci Jr DE Lanar, J Chromatogr B Biomed Sci Appl 2001 762 77 86 10.1016/S0378-4347(01)00340-1 11589461 (Pubitemid 32885585)
41. A recombinant baculovirus-expressed Plasmodium falciparum receptor-binding domain of erythrocyte binding protein EBA-175 biologically mimics native protein. H Liang DL Narum SR Fuhrmann T Luu BK Sim, Infect Immun 2000 68 3564 3568 10.1128/IAI.68.6.3564-3568.2000 10816512 (Pubitemid 30340458)
42. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. S Khusmith Y Charoenvit S Kumar M Sedegah RL Beaudoin SL Hoffman, Science 1991 252 715 718 10.1126/science.1827210 1827210 (Pubitemid 21917001)
43. Identification and characterization of the protective hepatocyte erythrocyte protein 17 kDa gene of Plasmodium yoelii, homolog of Plasmodium falciparum exported protein 1. DL Doolan RC Hedstrom WO Rogers Y Charoenvit M Rogers P de la Vega SL Hoffman, J Biol Chem 1996 271 17861 17868 10.1074/jbc.271.30.17861 8663412 (Pubitemid 26250764)
44. Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. MD Spring JF Cummings CF Ockenhouse S Dutta R Reidler E Angov E Bergmann-Leitner VA Stewart S Bittner L Juompan,, et al. PLoS One 2009 4 5254 10.1371/journal.pone.0005254 19390585
45. Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites. Y Charoenvit S Mellouk C Cole R Bechara MF Leef M Sedegah LF Yuan FA Robey RL Beaudoin SL Hoffman, J Immunol 1991 146 1020 1025 1988490
46. Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining. SG Smith MK Lalor P Gorak-Stolinska R Blitz NE Beveridge A Worth H McShane HM Dockrell, BMC Immunol 11 35
47. The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming. SM Todryk AA Pathan S Keating DW Porter T Berthoud F Thompson P Klenerman AV Hill, Immunology 2009 128 83 91 10.1111/j.1365-2567.2009.03073.x 19689738
48. Induction of CD4(+) T cell-dependent CD8(+) type 1 responses in humans by a malaria DNA vaccine. R Wang J Epstein FM Baraceros EJ Gorak Y Charoenvit DJ Carucci RC Hedstrom N Rahardjo T Gay P Hobart,, et al. Proc Natl Acad Sci USA 2001 98 10817 10822 10.1073/pnas.181123498 11526203 (Pubitemid 32878703)
49. CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein. Y Charoenvit VF Majam G Corradin JB Sacci Jr R Wang DL Doolan TR Jones E Abot ME Patarroyo F Guzman,, et al. Infect Immun 1999 67 5604 5614 10531206 (Pubitemid 29508076)
50. Allele-specificity of IFN-{gamma} Responses to the Carboxyl Terminal Region of Plasmodium Falciparum Merozoite Surface Protein 1 by Kenyan Adults with Naturally Acquired Immunity to Malaria. MD Spring K Chelimo DJ Tisch PO Sumba R Rochford CA Long JW Kazura AM Moormann, Infect Immun 78 4431 4441
51. A longitudinal study of malaria infection, morbidity and antibody titres in infants of a rural community in Ghana. BD Akanmori EA Afari H Sakatoku FK Nkrumah, Trans R Soc Trop Med Hyg 1995 89 560 561 10.1016/0035-9203(95)90107-8 8560540
52. Malaria infection, morbidity and transmission in two ecological zones Southern Ghana. EA Afari M Appawu S Dunyo A Baffoe-Wilmot FK Nkrumah, Afr J Health Sci 1995 2 312 315 12160443 (Pubitemid 127094631)
53. Humoral responses to Plasmodium falciparum blood-stage antigens and association with incidence of clinical malaria in children living in an area of seasonal malaria transmission in Burkina Faso, West Africa. I Nebie A Diarra A Ouedraogo I Soulama EC Bougouma AB Tiono AT Konate R Chilengi M Theisen D Dodoo,, et al. Infect Immun 2008 76 759 766 10.1128/IAI.01147-07 18070896 (Pubitemid 351251748)
54. Antibody-mediated growth inhibition of Plasmodium falciparum: relationship to age and protection from parasitemia in Kenyan children and adults. AE Dent ES Bergmann-Leitner DW Wilson DJ Tisch R Kimmel J Vulule PO Sumba JG Beeson E Angov AM Moormann,, et al. PLoS One 2008 3 3557 10.1371/journal.pone.0003557 18958285
55. Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. D Dodoo A Aikins KA Kusi H Lamptey E Remarque P Milligan S Bosomprah R Chilengi YD Osei BD Akanmori,, et al. Malar J 2008 7 142 10.1186/1475-2875-7-142 18664257
56. Antibody levels to multiple malaria vaccine candidate antigens in relation to clinical malaria episodes in children in the Kasena-Nankana district of Northern Ghana. D Dodoo F Atuguba S Bosomprah NA Ansah P Ansah H Lamptey B Egyir AR Oduro B Gyan A Hodgson,, et al. Malar J 10 108
57. Breadth and magnitude of antibody responses to multiple Plasmodium falciparum merozoite antigens are associated with protection from clinical malaria. FH Osier G Fegan SD Polley L Murungi F Verra KK Tetteh B Lowe T Mwangi PC Bull AW Thomas,, et al. Infect Immun 2008 76 2240 2248 10.1128/IAI.01585-07 18316390 (Pubitemid 351656161)
58. Naturally exposed populations differ in their T1 and T2 responses to the circumsporozoite protein of Plasmodium falciparum. WH Reece M Plebanski P Akinwunmi P Gothard KL Flanagan EA Lee M Cortina-Borja AV Hill M Pinder, Infect Immun 2002 70 1468 1474 10.1128/IAI.70.3.1468-1474.2002 11854234 (Pubitemid 34163425)
59. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types. EH Nardin JM Calvo-Calle GA Oliveira RS Nussenzweig M Schneider JM Tiercy L Loutan D Hochstrasser K Rose, J Immunol 2001 166 481 489 11123327 (Pubitemid 32038467)
60. Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein. MJ Lockyer K Marsh CI Newbold, Mol Biochem Parasitol 1989 37 275 280 10.1016/0166-6851(89)90159-X 2481827 (Pubitemid 19270007)
61. Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule. MF Good D Pombo IA Quakyi EM Riley RA Houghten A Menon DW Alling JA Berzofsky LH Miller, Proc Natl Acad Sci USA 1988 85 1199 1203 10.1073/pnas.85.4.1199 2448793 (Pubitemid 18073976)
62. Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. S Kumar LH Miller IA Quakyi DB Keister RA Houghten WL Maloy B Moss JA Berzofsky MF Good, Nature 1988 334 258 260 10.1038/334258a0 2456467
63. Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization. G Jiang Y Charoenvit A Moreno MF Baraceros G Banania N Richie S Abot H Ganeshan V Fallarme NB Patterson,, et al. Malar J 2007 6 135 10.1186/1475-2875-6-135 17925026
64. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. R Wang DL Doolan TP Le RC Hedstrom KM Coonan Y Charoenvit TR Jones P Hobart M Margalith J Ng,, et al. Science 1998 282 476 480 9774275 (Pubitemid 28483675)
65. Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein. R Wang J Epstein Y Charoenvit FM Baraceros N Rahardjo T Gay JG Banania R Chattopadhyay P de la Vega TL Richie,, et al. J Immunol 2004 172 5561 5569 15100299 (Pubitemid 38542058)
66. Acquired immunity to malaria. DL Doolan C Dobano JK Baird, Clin Microbiol Rev 2009 22 1 13 36 Table of Contents 10.1128/CMR.00025-08 19136431
67. A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray. PD Crompton MA Kayala B Traore K Kayentao A Ongoiba GE Weiss DM Molina CR Burk M Waisberg A Jasinskas,, et al. Proc Natl Acad Sci USA 107 6958 6963
68. Profiling humoral immune responses to P. falciparum infection with protein microarrays. DL Doolan Y Mu B Unal S Sundaresh S Hirst C Valdez A Randall D Molina X Liang DA Freilich,, et al. Proteomics 2008 8 4680 4694 10.1002/pmic.200800194 18937256